Ever-increasing lifestyle diseases in North America demands CVC?s for uncontamin

Posted by kenresearch on December 5th, 2017

Central venous catheter (CVC) is long, thin hollow plastic tube that is inserted into large vein of the neck or chest to administer fluid, nutrients, medicine and blood product or simply CVC’s are used for drug administration into a living body. CVC’s are also defined as central lines catheter or central venous access devices (CVADs). It was estimated that the use of CVC’s will increase drastically with the increasing number of aged population, cancer patients, cardiovascular disorders and population suffering from other chronic disease in North America. Population depending on central venous catheters are prone to bloodstream infections and increasing the treatment cost. The unfavourable events of central venous catheter are they are hazardous to patient, and expensive to treat which may indirectly hamper the growth of the CVC’s market.

According to the study “North America Central Venous Catheters Market Outlook to 2023”, the growing awareness in the American population about the antimicrobial technology and the increasing adoption of antimicrobial CVC’s has a positive impact on the growth of CVC’s market. CVC’s are majorly used to prevention and control of healthcare-associated infections and complications in hospitals, outpatient settings, and home healthcare settings. The central venous catheters market is segmented into antimicrobial, non-antimicrobial, and non-tunneled catheter devices. The non-tunneled CVCs accounted for the maximum shares of the central venous catheters CVC’s market. These are also known as subclavian, percutaneous, and short-term catheters which are used as an alternative to peripherally inserted central catheters (PICC). The central venous catheters market is again divided based on design type such as single lumen, double lumen and multi lumen. CVC’s composition is divided based on polyurethane, polyurethane/polycarbonate and silicone.

There are many leading players in the central venous catheters CVC’s market and they focus on providing a wide range of antimicrobial, non-tunneled, and tunneled catheter devices. Almost, all the manufacturers usually compete on pricing and technology upgrade of CVC’s. The leading players in the CVC’s market in North America are Teleflex, B. Braun Melsungen AG, C. R. Bard Inc, Vygon, Cook, Edwards Lifesciences Corp and Smiths Medical. Few other players are Amecath, AngioDynamics, BACTIGUARD, BD, Biosensors International, Boston Scientific, CONMED, Guangdong Baihe Medical Technology, Intra special catheters, isomed, Kimal, lepumedical, Medical Components, PRODIMED, SCW MEDICATH, SILMAG, Smiths Medical, Terumo, TROGE MEDICAL, TUOREN Medical, VOGT MEDICAL, and ZOLL Medical.

CVC’s are majorly used in ambulatory surgical centres (ASC), and hospitals which includes multi-specialty hospitals, private hospitals, and hospital groups. Majority of the hospitals performing dialysis procedures for urological and renal disorders experience an increased influx of patients and a large number of catheterization is required. The central venous catheters manufacturing cost analysis includes cost involved for raw materials, labor and manufacturing expenses. This also includes distribution, market concentration and fluctuations in price trends. The introduction of healthcare reforms and safety guidelines in North America are the key factors that will have a positive impact on CVC’s market growth over the coming years.

To know more, click on the link below

https://www.kenresearch.com/healthcare/medical-devices/north-america-central-venous-catheters-market/135967-91.html